IT1239542B - Composizione farmaceutica comprendente piroxicam e procedimento per lasua preparazione - Google Patents

Composizione farmaceutica comprendente piroxicam e procedimento per lasua preparazione

Info

Publication number
IT1239542B
IT1239542B IT22164A IT2216489A IT1239542B IT 1239542 B IT1239542 B IT 1239542B IT 22164 A IT22164 A IT 22164A IT 2216489 A IT2216489 A IT 2216489A IT 1239542 B IT1239542 B IT 1239542B
Authority
IT
Italy
Prior art keywords
lasua
procedure
preparation
pharmaceutical composition
composition including
Prior art date
Application number
IT22164A
Other languages
English (en)
Other versions
IT8922164A0 (it
IT8922164A1 (it
Inventor
Pal Fekete
Denes Bezzegh
Istvan Simonyi
Biborka Maroshelyi
Katalin Zukovics
Janos Tombor
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of IT8922164A0 publication Critical patent/IT8922164A0/it
Publication of IT8922164A1 publication Critical patent/IT8922164A1/it
Application granted granted Critical
Publication of IT1239542B publication Critical patent/IT1239542B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IT22164A 1988-10-28 1989-10-27 Composizione farmaceutica comprendente piroxicam e procedimento per lasua preparazione IT1239542B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU885621A HU200926B (en) 1988-10-28 1988-10-28 Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules

Publications (3)

Publication Number Publication Date
IT8922164A0 IT8922164A0 (it) 1989-10-27
IT8922164A1 IT8922164A1 (it) 1991-04-27
IT1239542B true IT1239542B (it) 1993-11-05

Family

ID=10970484

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22164A IT1239542B (it) 1988-10-28 1989-10-27 Composizione farmaceutica comprendente piroxicam e procedimento per lasua preparazione

Country Status (9)

Country Link
JP (1) JPH02172918A (it)
AT (1) AT399277B (it)
CA (1) CA2001673C (it)
DE (1) DE3936112C2 (it)
FR (1) FR2638357B1 (it)
GB (1) GB2224207B (it)
HU (1) HU200926B (it)
IL (1) IL92138A (it)
IT (1) IT1239542B (it)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2642486B2 (ja) * 1989-08-04 1997-08-20 田辺製薬株式会社 難溶性薬物の超微粒子化法
JP2964195B2 (ja) * 1992-04-28 1999-10-18 エスエス製薬株式会社 ピロキシカム錠及びその製造法
DE19603402A1 (de) * 1995-02-24 1996-08-29 Basf Ag Weichgelatinekapseln
DE69739967D1 (de) 1996-06-14 2010-09-30 Kyowa Hakko Kirin Co Ltd Eine im Mund schnell zerfallende Tablette
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US6964779B1 (en) * 1998-04-08 2005-11-15 Kyowa Hakko Kogyo Co., Ltd. Tablet manufacturing method and tablet
JP2000095674A (ja) * 1998-09-22 2000-04-04 Sato Pharmaceutical Co Ltd 口腔内崩壊時間短縮化錠剤の製造方法及び装置
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
BR0317349A (pt) * 2002-12-16 2005-11-16 Kissei Pharmaceutical Droga sólida para uso oral
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ589750A (en) 2004-10-21 2012-07-27 Aptalis Pharmatech Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
CN101232905B (zh) * 2005-07-25 2013-01-09 大塚制药株式会社 一种用于测量嘧啶代谢能力的口服制剂
JP5309262B2 (ja) 2009-12-02 2013-10-09 アプタリス ファーマ リミテッド フェキソフェナジン・マイクロカプセル及びそれを含む組成物
KR102105354B1 (ko) 2012-08-20 2020-04-29 오츠카 세이야쿠 가부시키가이샤 당대사능의 측정 방법 및 그에 사용하는 조성물
JP6305392B2 (ja) 2013-03-15 2018-04-04 大塚製薬株式会社 脂肪酸燃焼によるインスリン抵抗性の測定方法、並びにそれに使用する組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
GB1308533A (en) * 1969-06-02 1973-02-21 Pfizer Benzothiazine dioxides as anti-thombotic agents
JPS55129221A (en) * 1979-03-29 1980-10-06 Kaken Pharmaceut Co Ltd Preparation of oral preparation containing hardly soluble medicine
US4350689A (en) * 1980-02-15 1982-09-21 American Cyanamid Company Combinations of agents which give enhanced anti-inflammatory activity
US4434164A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts
RO88420A (ro) * 1983-04-25 1986-01-30 Pfizer Inc,Us Procedeu pentru prepararea unor saruri bazice de piroxican depuse pe suporturi farmaceutice
DE3419128A1 (de) * 1984-05-23 1985-11-28 Bayer Ag, 5090 Leverkusen Dihydropyridinpraeparate und verfahren zu ihrer herstellung
CH663899A5 (fr) * 1985-03-20 1988-01-29 Nestle Sa Procede pour la preparation d'une composition a base d'un principe actif de faible hydrosolubilite finement divise.
ES545221A0 (es) * 1985-07-02 1986-01-01 Ferrer Int Procedimiento de obtencion de particulas de 4-hidroxi-2-me- til-n-2-piridil-2h-1,2-benzotiazina-3-carboxamida-1,1-dioxi-do(piroxicam) recubiertas

Also Published As

Publication number Publication date
CA2001673C (en) 1996-08-27
IL92138A (en) 1994-08-26
GB2224207B (en) 1992-06-10
JPH02172918A (ja) 1990-07-04
HU200926B (en) 1990-09-28
FR2638357B1 (fr) 1993-10-22
DE3936112A1 (de) 1990-05-31
CA2001673A1 (en) 1990-04-28
IT8922164A0 (it) 1989-10-27
GB8924286D0 (en) 1989-12-13
HUT51143A (en) 1990-04-28
FR2638357A1 (fr) 1990-05-04
ATA247489A (de) 1994-09-15
GB2224207A (en) 1990-05-02
IL92138A0 (en) 1990-07-12
IT8922164A1 (it) 1991-04-27
DE3936112C2 (de) 1999-02-18
AT399277B (de) 1995-04-25

Similar Documents

Publication Publication Date Title
IT1231434B (it) Composizione farmaceutica endovenosa e procedimento per la sua preparazione.
DE10199066I1 (de) Pharmazeutische Zusammensetzung
MX17752A (es) Formulaciones farmaceuticas y procedimiento para prepararlas
DE3486441T2 (de) 3-Hydroxypyrid-4-one und pharmazeutische Zusammensetzungen
NZ233320A (en) 3-substituted-2-oxo-indole derivatives and pharmaceutical compositions
FR2636532B1 (fr) Compositions pharmaceutiques
LV10573A (lv) Panemiens farmaceitiska sastava iegusanai
DK489189A (da) Farmaceutisk praeparat
IT1239542B (it) Composizione farmaceutica comprendente piroxicam e procedimento per lasua preparazione
IT8820073A0 (it) Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
NZ233790A (en) Benzocycloalkane derivatives and pharmaceutical compositions
DE69024843D1 (de) Rhodanin-Derivate und pharmazeutische Zusammensetzungen
DK496889D0 (da) Peptidholdigt farmaceutisk praeparat
DK603988D0 (da) Farmaceutisk praeparat
NZ236483A (en) Glycerol derivatives and pharmaceutical compositions thereof
DK336489A (da) Farmaceutisk praeparat
NZ233013A (en) Substituted thieno-triazolo-diazepine derivatives and pharmaceutical compositions
ATA133288A (de) Pharmazeutische zusammensetzung
ATA321188A (de) Pharmazeutische zubereitung
DK37589D0 (da) Farmaceutisk praeparat for 4-aroylimidazol-2-oner
NZ228281A (en) Tricyclo-amine derivatives and pharmaceutical compositions
DE3871159D1 (de) Pharmazeutische und tieraerztliche zusammensetzungen.
IT1224244B (it) Composizione farmaceutica anoressizzante comprendente 5-idrossitrpofano
DK638889A (da) Farmaceutisk kombinationspraeparat
IT1216894B (it) Composizione farmaceutica eprocedimento per la sua preparazione.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971030